CONNECTIVE TISSUE DISEASES
Clinical trials for CONNECTIVE TISSUE DISEASES explained in plain language.
Never miss a new study
Get alerted when new CONNECTIVE TISSUE DISEASES trials appear
Sign up with your email to follow new studies for CONNECTIVE TISSUE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for PAH patients: Long-Term drug safety trial underway
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of the drug ralinepag in people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. About 1,000 adults who have already been in earlier ralinepag studies will take the drug and be monitored f…
Matched conditions: CONNECTIVE TISSUE DISEASES
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Could ifetroban ease scleroderma lung damage?
Disease control OngoingThis study tests an experimental drug called ifetroban in people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis) or scleroderma-related high blood pressure in the lungs. The goal is to see if the drug is safe and can improve lung function. About 34 adults…
Matched conditions: CONNECTIVE TISSUE DISEASES
Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated May 05, 2026 11:55 UTC